Loading...
•
Dec 31, 2021
Bausch Health Q4 2021 Earnings Report
Bausch Health's Q4 2021 financial results were announced, revealing revenues of $2.196 billion and GAAP net income of $69 million. The company also provided 2022 guidance.
Key Takeaways
Bausch Health Companies Inc. reported Q4 2021 revenues of $2.196 billion and GAAP net income of $69 million. The company's full-year revenue grew by 5% compared to the previous year, driven by key products gaining market share and new product launches. Bausch Health has filed public registration statements for Bausch + Lomb and Solta and is prepared to launch both IPOs.
Revenues for Q4 2021 reached $2.196 billion.
GAAP Net Income for Q4 2021 was $69 million.
Adjusted EBITDA (non-GAAP) for Q4 2021 was $909 million.
GAAP Cash Generated from Operations for Q4 2021 was $24 million.
Revenue by Segment
Forward Guidance
Bausch Health provided guidance for the full year of 2022 with revenue range of $8.40 - $8.60 billion and Adjusted EBITDA range of $3.45 - $3.60 billion.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...